Relugolix

SH

Shenzhen Haorui Pharmatech Co., Ltd.

Supplier · Active Pharmaceutical Ingredients (APIs)China

Basic Information

1.3K

68

21

3.8(38)

Category

Biopharmaceutical Products

Subcategory & Sub-subcategory

Biopharmaceuticals (General) / Prophylactic Biological Products

Trade Type

Sell

Product Name

Relugolix

Details

Substance

Manufacturer(s)

Shenzhen Haorui Pharmatech Co., Ltd. - China

Specifications

EC Number: 864-997-1
CAS Number: 737789-87-6
IUPAC Name: 1-[4-[1-[(2,6-difluorophenyl)methyl]-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxothieno[2,3-d]pyrimidin-6-yl]phenyl]-3-methoxyurea
Application: GnRH receptor antagonist for uterine fibroids and advanced prostate cancer
Molecular Weight: 623.6
Chemical Formula: C₂₉H₂₇F₂N₇O₅S
Regulatory Status: Approved in Japan (2019, Relumina) and by US FDA (2020, Orgovyx)

Documents

US FDA

FDA audit approved and EDQM approved

Ratings

(0)

(0)

(0)

(0)

(0)

Leave your rating & comment

Comments

Filters:

Sort by:

No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Similar Products & Services

Products & Services related to what you're viewing

People Also Viewed

Other products & services viewed by people who looked at this product